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has potential beneﬁ t as a basic educational tool for students and health professionals 
interested in exploring these analytical approaches. 
CONCEPTUAL PAPERS & RESEARCH ON METHODS – Modeling Methods
PMC4
CHOOSING THE RIGHT DISTRIBUTION WHEN PERFORMING 
PROBABILISTIC SENSITIVITY ANALYSIS: RELATIVE RISKS AND THE 
TRIANGULAR DISTRIBUTION A SIMULATION STUDY
Kim H1, Gurrin L2, Liew D1
1The University of Melbourne, Fitzroy, Victoria, Australia; 2University of Melbourne, Carlton, 
Victoria, Australia
OBJECTIVES: In economics the triangular distribution is often used when limited 
information is available for different parameters. This is also the case in health eco-
nomic modeling when performing probabilistic sensitivity analysis (PSA). In PSA, 
distributions are assigned to input parameters in order to assess the uncertainty in the 
model. One of the main criticisms of PSA is that the distributions can be chosen 
arbitrarily. Analysts can thereby manipulate the choice of distributions to bias the 
results. This study investigates the usage of the triangular distribution for describing 
the uncertainty of relative risks (RR) compared to the lognormal distribution and 
empirical distribution RR generated through simulations. METHODS: Ten thousand 
simulations of the triangular distribution, the log normal distribution and relative risks 
constructed from two binomial distributions were performed. Descriptive statistics 
and graphical plots were constructed. RESULTS: The triangular distribution does not 
have the support of the full positive real axis and as such extreme values, such as very 
small and very large numbers, have a zero probability of being measured. However, 
values around the mode are prone to be drawn with a higher probability compared 
to both the exact values and the log normal distribution. The lognormal distribution 
tends to overestimate the RR compared to the empirical distribution. CONCLU-
SIONS: This study shows that the triangular distribution is a poor choice for charac-
terizing the uncertainty of RR. The overestimation of the RR can introduce bias, for 
instance, if used for responder rates or death rates. The lognormal distribution appears 
to be a better approximation, but if the actual number of events and total number of 
exposed are available, the empirical simulation is of course preferred. 
CONCEPTUAL PAPERS & RESEARCH ON METHODS – Patient-Reported 
Outcomes Studies
PMC6
ESTIMATING EQ-5D TARIFFS FOR MALAYSIA USING TIME TRADE OFF 
AND VISUAL ANALOGUE SCALE
Aryani Md Yusof F1, Goh A2, Azmi S2
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Bhd, Petaling Jaya, Selangor, Malaysia
OBJECTIVES: This research aimed to estimate utility tariffs for Malaysia using Time 
Trade Off (TTO) and Visual Analogue Scale (VAS) valuations of the EQ-5D descrip-
tive system. METHODS: TTO and VAS valuations were obtained from face to face 
surveys in 2004 and 2005 of 152 adult patients, their care-givers and health profes-
sionals at six government hospitals in Malaysia. The survey closely followed the 
methodology of EQ5D health states by Shaw et al. Forty-ﬁ ve EQ-5D health states 
were valued, divided into ﬁ ve sets of 15 health states each. Each respondent was asked 
to value one set of 15 health states. Each respondent performed a ranking, the VAS 
and TTO valuations. TTO allowed for scoring health states as worse than death. 
Linear additive regression models were performed. Dependent variables were the 
rescaled VAS and TTO values. Independent variables were two dummy variables for 
each of the ﬁ ve EQ-5D dimensions and two pre-deﬁ ned interaction terms, N3 and 
D1. RESULTS: A total of 152 respondents were obtained with mean age 41 years and 
self-assessed VAS of 82. Respondents reported TTO valuations to be difﬁ cult or more 
difﬁ cult (16%) than VAS valuation (8%). A greater number of VAS valuations had 
no inconsistencies compared to TTO valuations (63% and 17% respectively). All N3 
and D1 models were statistically signiﬁ cant. Goodness-of-ﬁ t was better in VAS models 
(adjusted R2 0.755 and 0.757) than N3 models (adjusted R2 0.424 and 0.412). All 
the independent variables in the models were statistically signiﬁ cant and theoretically 
consistent with expected signs and magnitude, with level 3 coefﬁ cients larger than 
level 2 coefﬁ cients for the same health dimension. CONCLUSIONS: Both N3 and D1 
model speciﬁ cations were applicable to Malaysian EQ-5D health valuations. VAS 
valuations appear to be better than TTO. 
PMC7
TRANSLATING ITEM BANKS: BENEFITS AND CHALLENGES
Arnold BJ1, Lent L1, Correia H2, Cella D2
1FACIT.org Translations, Elmhurst, IL, USA; 2Northwestern University, Chicago, IL, USA
With the emergence of electronic data collection and efforts to reduce respondent 
burden, the use of item banks to measure health related constructs—especially within 
federally funded (NIH) research—has become more mainstream. Following the use 
and acceptance of Computer Adaptive Testing (CAT) in educational testing, item 
banks in health status assessment allow for better measurement of a construct across 
the measurement continuum. As with standard static questionnaires used in outcomes 
assessment, there is a need for multilingual translations of item banks in order to 
establish and compare item hierarchies across varying languages and cultures. Transla-
tion and validation of items contained in item banks presents interesting scientiﬁ c 
opportunities for cross-cultural health assessment, but there are also attendant chal-
lenges to be addressed. This presentation will give a brief overview of the beneﬁ ts of 
computer adaptive testing while outlining the most salient issues related to the evalu-
ation of item difﬁ culty and hierarchy. It will also highlight differences and unique 
challenges brought about by translating item banks. Topics such as maintaining 
consistent terminology, recall period and verb tense will be addressed and examples 
from our experience will be provided. Appropriate translation methodology, copyright 
issues and the role of both qualitative and quantitative data in the process will also 
be discussed as well as brief examples of how items that are similar linguistically and 
conceptually may have different item parameters in different languages. 
PMC8
PREDICTING THE SF-6D PREFERENCE-BASED INDEX SCORE USING 
THE SF-8 HEALTH SURVEY
Wang P1, Luo N1, Wee HL2, Tai ES1, Lee J1, Thumboo J3
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OBJECTIVES: This study aimed to develop a function to predict the SF-6D index 
score from SF-8 scores. METHODS: This study was a secondary analysis of data 
collected in a population health survey in Singapore in which respondents (n = 7529) 
completed both the SF-36 and the SF-8 questionnaires. Four multiple linear regression 
models with different speciﬁ cations were compared for their performance in predicting 
SF-6D scores calculated using responses to SF-8 items. RESULTS: The model in which 
responses to all SF-8 items were coded into dummy variables achieved the best predic-
tion outcomes. The model explained 62% (other models: 56% to 62%) of the variance 
in the SF-6D index score with the mean absolute error being 0.056 (other models: 
0.056 to 0.06100) and root mean square error being 0.076 (other models: 0.077 to 
0.083). The absolute error between predicted and observed SF-6D scores was less than 
0.1 and 0.05 among 84% and 59% of the respondents, respectively; this results for 
other modes were 77% to 84% and 51% to 56%. CONCLUSIONS: It is possible to 
generate a utility-based index score from the SF-8. The function developed in this 
study should be further tested in other populations. 
CONCEPTUAL PAPERS & RESEARCH ON METHODS – Statistical Methods
PMC10
NONPARAMETRIC METHODS FOR VALUE OF INFORMATION 
ANALYSIS OF CLINICAL TRIALS
Sadatsafavi M1, McCandless L2, Marra C1
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While the value of information (VoI) methods have been developed for model based 
cost-effectiveness analyses (CEA), there is a gap in applying such methods to CEAs 
conducted alongside clinical trials. In the present it is shown that by treating the 
probability distribution of net beneﬁ ts within each trial arm as a random quantity, 
calculations for the Expected Value of Sample Information (EVSI) for model-based 
CEAs can be extended to the setting of a trial-based CEA where individual net beneﬁ ts 
from subjects are available. In this case EVSI calculates the expected return of invest-
ment from conducting a future trial with the similar design as a function of its sample 
size. Based on such analogy, a nonparametric method for EVSI calculation based on 
two-level bootstrap is introduced. At the ﬁ rst level, a Bayesian bootstrap (Rubin, 1981) 
from the vector of individual-level net beneﬁ ts within each arm of the trial is per-
formed. The empirical distribution of such a bootstrap sample amounts to a random 
draw from the ‘posterior distribution of the distribution’ of net beneﬁ ts given the 
observed data. A second bootstrap from this sample then models the distribution of 
net beneﬁ ts in the future study. The data of the future and current trials will be 
combined to identify the maximum net beneﬁ t and the cycle is repeated over several 
iterations. We also extend this framework to address parametric analysis (e.g., net 
beneﬁ t regression), missing values, and incorporation of external evidence. We use 
data from a randomized clinical trial of combination therapy in COPD as an applica-
tion. Since the two-level bootstrap directly generates samples of the individual-level 
data for the future trial, it allows modeling realistic scenarios (e.g., missing values, 
complex statistical analysis). This, combined with the nonparametric nature of the 
method, should provide a robust framework for VoI analysis for trial-based CEAs. 
MENTAL HEALTH – Clinical Outcomes Studies
PMH1
METABOLIC SYNDROME AND SECOND GENERATION 
ANTIPSYCHOTICS UTILIZATION—IMPACT OF PSYCHIATRIC 
COMORBIDITY AND POLYPHARMACY
Yang HK, Simoni-Wastila L, Mullins CD, Palumbo F, Onukwugha E, Noel JM
University of Maryland School of Pharmacy, Baltimore, MD, USA
OBJECTIVES: Current studies examining metabolic effects associated with second 
generation antipsychotics (SGAs) do not consider the impact of psychiatric comorbidi-
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ties or medications. This study aimed to determine the association of metabolic syn-
drome (MetS) and SGA use, and the incremental contributions of select psychiatric 
comorbidities and polypharmacy. METHODS: We applied descriptive and regression 
analyses to a large administrative claims database of antipsychotic users to examine 
the association between SGAs (aripiprazole, ziprasidone, risperidone, quetiapine, and 
olanzapine) and MetS, as well as the effects of psychiatric comorbidity and polyphar-
macy. Select psychiatric comorbidities included schizophrenia, bipolar, depression, 
and other psychiatric disorders. Psychiatric polypharmacy was deﬁ ned as concomitant 
use of antipsychotics with other psychiatric drugs with metabolic effects (selective 
serotonin reuptake inhibitors [SSRIs], tricyclic antidepressants [TCAs], other antide-
pressants, and mood stabilizers). RESULTS: Of 50,128 antipsychotic users, the preva-
lence of MetS was lower in SGA users than non-SGA users (7.6% vs. 12.8%; P < 
0.0001), who were older and had higher prevalence of MetS components. However, 
SGA users exhibited more indicators of psychiatric severity, as evidenced through 
higher prevalence of psychiatric disorders and higher concomitant use of other psy-
chiatric drugs. Multivariable regression analysis showed the odds of MetS was lower 
in SGA users (OR = 0.86; P < 0.001) than non-SGA users. Concomitant use of SSRIs 
and TCAs signiﬁ cantly increased the odds of having MetS (OR = 1.26 and 1.29, 
respectively), as did diagnoses of schizophrenia, bipolar or depression disorders (OR 
= 1.22, 1.18, 1.12, respectively) (all P < 0.001). CONCLUSIONS: Psychiatric comor-
bidity and polypharmacy signiﬁ cantly increase the odds of MetS in antipsychotic users. 
Findings demonstrate the need for practitioners to consider patients’ psychiatric 
comorbidity and polypharmacy burdens when prescribing SGAs. Results suggest that 
prescribers of SGAs may be aware of metabolic effects and therefore prescribe non-
SGAs to their more metabolically-vulnerable patients. Further research into the com-
plexities of treatment patterns and outcomes in this comorbid population is 
warranted. 
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EARLY RESPONSE PREDICTS SUBSEQUENT RESPONSE TO 
OLANZAPINE LONG-ACTING INJECTIONS IN THE TREATMENT OF 
SCHIZOPHRENIA
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OBJECTIVES: Early nonresponse to oral antipsychotics was previously shown to be 
a robust predictor of subsequent nonresponse to continued treatment with the same 
medication in the treatment of schizophrenia. This study assessed whether early 
response or early nonresponse to treatment can serve as a clinical marker in the treat-
ment of schizophrenia with an atypical antipsychotic in long-acting injection formula-
tion (depot). METHODS: This post hoc analysis used data (n = 233) from an 8-week 
randomized, double-blind placebo-controlled study of olanzapine long-acting injection 
(olanzapine-LAI) in the treatment of inpatients with schizophrenia. Early response to 
olanzapine-LAI was deﬁ ned as ≥30% improvement on the PANSS total score (scored 
0–6) from baseline to 4 weeks of treatment. Subsequent response was deﬁ ned as ≥40% 
improvement on the PANSS total score from baseline to endpoint. Predictive accuracy 
was assessed by calculating sensitivity, speciﬁ city, positive predictive value (PPV), 
negative predictive value (NPV), and overall predictive accuracy. Early responders and 
early non-responders to olanzapine-LAI were also compared on change in clinical and 
functional outcome measures. RESULTS: Early response/nonresponse to olanzapine-
LAI, assessed following 4 weeks of treatment, predicted subsequent response/nonre-
sponse with a high level of overall accuracy (79%), sensitivity (85%), speciﬁ city 
(72%), PPV (78%), and NPV (80%). Compared to early non-responders, early 
responders had signiﬁ cantly longer time to all-cause treatment discontinuation, greater 
symptom improvement at all time points (per PANSS total and subscale scores), and 
greater improvement in quality of life and level of social functioning (all at P ≥ 0.01). 
CONCLUSIONS: In this study of inpatients with schizophrenia, early response to 
olanzapine long-acting injection was found to be a robust predictor of subsequent 
response to the medication. Early responders experienced signiﬁ cantly better clinical 
and functional outcomes compared to early non-responders and had longer treatment 
duration. Current ﬁ ndings are consistent with previous research on oral antipsychotics 
and will require replication in future studies. 
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A MULTILEVEL ANALYSIS OF AREA AND INDIVIDUAL EFFECTS ON 
METHADONE MAINTENANCE TREATMENT IN TAIWAN
Chen CY1, Ting SY2, Tan HKL3, Yang MC1
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OBJECTIVES: Many studies have shown that the methadone maintenance treatment 
(MMT) can effectively and safely reduce heroin use. However, most studies only 
evaluated and compared drug treatment programs, but did not investigate the inﬂ u-
ence of area of treatment on individual behaviors and treatment outcome. This study, 
therefore, aimed to evaluate direct effects of area-level characteristics and interactive 
effects of area-level characteristics and individual characteristics on Methadone main-
tenance treatment, after considering individual-level characteristics in Taiwan. 
METHODS: All opioid-dependent persons from ﬁ ve hospitals in 2009 who were 
participating in the outpatient methadone maintenance program for the ﬁ rst time and 
met eligibility criteria were enrolled into the study. The impact of MMT on self–
perceived health status was assessed by the case manager of each hospital. Health 
status and treatment outcome were investigated at the ﬁ rst outpatient visit and at 
3-month follow-ups. Individual level and area level characteristics were also assessed. 
Multilevel linear models were used to estimate if the differences of quality of life and 
opioid treatment index before and after the MMT were signiﬁ cant. RESULTS: A total 
of 330 opioid-dependent patients were recruited in the study. During the follow-up 
period, 38% of participants completed study (N = 127). The mean age of study 
participants was 35 years. Most of participants were male, single, low education level, 
unemployed and smoking. Patients under MMT had statistically signiﬁ cant improve-
ments in total quality of life (t = −4.293, P < 0.000), opioid treatment index (OTI) (t 
= 8.44, P < 0.000), and the satisfaction of quality of life (t = −4.498, P < 0.000). 
Furthermore, our result indicated that the schizophrenic and older patients had sig-
niﬁ cantly poorer results. In addition, area of treatment was also signiﬁ cantly associ-
ated with OTI. CONCLUSIONS: MMT improves the quality of life of patients and 
reduce drug abuse problems. However, actions should be taken to minimize the varia-
tions among areas of treatment. 
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LABOR FORCE WITHDRAWAL OF PATIENTS WITH PSYCHIATRIC 
ILLNESS IN TAIWAN
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OBJECTIVES: This study aimed to estimate the withdrawal rate from the labor 
market among patients with schizophrenia or bipolar/depression in Taiwan. 
METHODS: The data source was the Psychiatric Inpatients Medical Claims Data 
(PIMC) from the National Health Research Institute (NHRI), Taiwan. The PIMC 
compiled all the health records during 1996–2008 for patients who had at least one 
psychiatric hospitalization during 1996–2001. The inclusion criteria were patients 
who: 1) had their initial psychiatric health record within 1998 to 2001; 2) had primary 
or secondary ICD-9-CM diagnosis of schizophrenia, bipolar or depression; 3) were 
under employment; and 4) were aged between 18 and 65. The ﬁ nal sample available 
for the analyses was 23,174 (11,970 for schizophrenia; 11,204 for bipolar/depression). 
An index date was created by subtracting 365 days from the date of initial health 
record for examining the impact of the disease on withdrawal pre and post of disease 
onset. To identify all withdrawal events, each case was tracked from the index date 
until December 31, 2008 or death, whichever came ﬁ rst. Women without events were 
censored on December 31, 2008. Kaplan–Meier method was used to estimate cumu-
lated employment rates. RESULTS: For patients with schizophrenia, withdrawal rate 
of 34% was found during 1 year before the disease onset. During 1 year before and 
one after the disease onset, the withdrawal rate increased to 52%. During 1 year before 
and 4 years after the disease onset, the rate raised to 78%. Similar patterns were 
observed for patients with bipolar/depression, with the corresponding rate equaling 
34%, 52%, and 75%. Median employment time (95% CI) was 672.0 days (645.0, 
698.0) for patients with schizophrenia, and 689.5 days (662.0 to 712.0) for patients 
with bipolar/depression. CONCLUSIONS: Schizophrenia, bipolar and depression 
were showed to have adverse impacts on labor participation. 
MENTAL HEALTH – Cost Studies
PMH5
A DIRECT MEDICAL COST ANALYSIS OF GEROPSYCHIATRIC 
PATIENTS IN TAIWAN
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OBJECTIVES: The aims of this study are to estimate the direct medical costs and 
utilization rate of psychiatric services among elder people (aged 65 and over) in 
Taiwan, and to evaluate the costs of the top ﬁ ve geriatric mental disorders. METHODS: 
This study was based on the National Health Insurance Research Database of Tai-
wan’s National Health Insurance (NHI) program. Detailed data was extracted from 
the Psychiatric Inpatient Medical Claim (PIMC) dataset. The PIMC included 96,013 
psychiatric inpatients’ data from 1996 to 2007. RESULTS: From 2002 through 2007, 
the sample included 15,109 (16% of all psychiatric inpatients) geropsychiatric inpa-
tients. The total admissions were 19,137 and the hospitalization rate was 1.27 per 
person per year. The average LOS (length of stay) was 35.05 days (acute bed), 78.71 
days (chronic bed), and average ambulatory visits were 9.48 per patient per year. The 
mean total hospital-related cost was USD 7.2 million and the mean cost for each 
patient was USD 2828 per year. The top ﬁ ve ranking mental disorders and their 
average costs per year were dementia (987 patients, USD 2.6 million), mood disorders 
(616, USD 1.6), schizophrenia (276, USD 1.0), other organic brain disorders (254, 
USD 0.6), and delusional disorders (149, USD 0.9). CONCLUSIONS: From 2002 
through 2007, the direct medical costs and utilization rate of psychiatric facilities by 
geropsychiatric inpatients increased annually in Taiwan. The direct medical costs of 
dementia, mood disorder and schizophrenia were signiﬁ cantly higher than those of 
the other mental disorders. The direct medical expenditures estimated in this study 
have implications for assessment of ﬁ nancial impact on future insurance budget plan-
ning in Taiwan. 
